
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 25, 2025, titled "Company forays into Oncology lwith Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers. ".
Filed with NSE ·

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 25, 2025, titled "Company forays into Oncology lwith Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers. ".
6ix hasn’t read this filing yet.
GlaxoSmithKline Pharmaceuticals Limited on 6ix
Follow GlaxoSmithKline Pharmaceuticals into a list and get an email when it puts out news.
Follow GlaxoSmithKline Pharmaceuticals